WallStreetZenWallStreetZen

NASDAQ: NEO
Neogenomics Inc Stock Ownership - Who owns Neogenomics?

Insider buying vs selling

Have Neogenomics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Lynn A. TetraultDirector2024-03-046,112$15.97
$97.58kSell
Alicia C. OlivoGeneral Counsel2024-02-152,587$14.96
$38.71kSell
Alicia C. OlivoGeneral Counsel2023-11-172,669$18.39
$49.08kSell
Lynn A. TetraultDirector2023-05-221,507$11.60
$17.48kBuy

1 of 1

NEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NEO insiders and whales buy or sell their stock.

NEO Shareholders

What type of owners hold Neogenomics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.66%19,980,993$276.74MInstitution
Electric Co General11.75%15,000,000$207.75MInsider
Vanguard Group Inc11.10%14,169,665$196.25MInstitution
Brown Advisory Inc7.56%9,643,599$133.56MInstitution
Peter M. Peterson6.43%8,202,050$113.60MInsider
Steven C. Jones5.79%7,393,510$102.40MInsider
T Rowe Price Investment Management Inc5.00%6,382,515$88.40MInstitution
Janus Henderson Group PLC4.98%6,348,613$87.93MInstitution
Michael T. Dent3.88%4,952,750$68.60MInsider
Kinderhook LP3.80%4,848,334$67.15MInsider

1 of 3

NEO vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NEO72.39%27.61%Net SellingNet Selling
MYGN92.31%7.69%Net SellingNet Selling
TWST88.25%11.75%Net SellingNet Selling
GH64.42%35.58%Net SellingNet Selling
OPK17.43%82.57%Net BuyingNet Buying

Neogenomics Stock Ownership FAQ

Who owns Neogenomics?

Neogenomics (NASDAQ: NEO) is owned by 98.53% institutional shareholders, 37.57% Neogenomics insiders, and 0.00% retail investors. Electric Co General is the largest individual Neogenomics shareholder, owning 15.00M shares representing 11.75% of the company. Electric Co General's Neogenomics shares are currently valued at $205.20M.

If you're new to stock investing, here's how to buy Neogenomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.